Dieses Ergebnis aus Springer Nature Journals kann Gästen nicht angezeigt werden. Login für vollen Zugriff.

A phase II, randomized, open-labeled study to evaluate low-dose pembrolizumab in addition to neoadjuvant chemotherapy for triple-negative breast cancer (TNBC)

Title:	A phase II, randomized, open-labeled study to evaluate low-dose pembrolizumab in addition to neoadjuvant chemotherapy for triple-negative breast cancer (TNBC)
Authors:	Arora, Adhip^Aff1; Seenu, V.^Aff2; Parshad, Rajinder^Aff2; Bansal, V. K.^Aff2; Dhar, Anita^Aff2; Mathur, Sandeep^Aff3; Tanwar, Pranay^Aff4; Mishra, Piyush^Aff2; Kataria, Kamal^Aff2; Suhani^Aff2; Gogia, Ajay^Aff1; Kumar, Brijesh^Aff2; Haresh, K. P.^Aff5; Mallick, Supriya^Aff5; Saini, Surendra Kumar^Aff5; Mishra, Ashutosh^Aff6; Bansal, Babul^Aff6; Sharma, Jyoti^Aff6; Saikia, Jyoutishman^Aff6; Rangarajan, Krithika^Aff7; Dhamija, Ekta^Aff7; Prasad, Chandra Prakash^Aff4; Shamin, Shamim Ahmed^Aff8; Agastm, Sourabh^Aff9; Kalra, Kaushal^Aff10; Vishvam, Divvay^Aff10; Mani, Kalaivani^Aff11; Kumar, Akash^Aff1; Bakhshi, Sameer^Aff1; Batra, Atul^{Aff1, IDs13063025087269_cor1}
Source:	Trials. 26(1)
Database:	Springer Nature Journals